Tuesday, June 24, 2025 6/24/2025

Generating kidney organoids and mature renal cell types via directed iPSC differentiation

Award Number: UH3DK107344
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/25/2015
PERIOD OF PERFORMANCE END DATE: 08/31/2020

Group Awards By:

View Award Description

Generating kidney organoids and mature renal cell types via directed iPSC differentiation - DESCRIPTION (provided by applicant): Generating kidney organoids and mature renal cell types via directed iPSC differentiation. Chronic kidney disease is increasing in prevalence by 6.3% per annum. Hence there is a desperate need for the development of novel treatments. The aim of the proposal is to direct the differentiation of human pluripotent stem cells towards kidney organoids containing all four key progenitor cells capable of generating a mature organ, including the nephrogenic mesenchyme, ureteric epithelium, stroma and vascular progenitors. These organoids will serve as a source of specific kidney cell types of value for cellular therapy as well as an accurate model of the organ as a whole. The proposal draws on our published data defining the methodology for generating kidney organoids and our experience in the generation of reporter iPSC lines. Results from the studies proposed will generate tools for the research community (a suite a reporter cell lines), knowledge about the development of the kidney in humans, improved methods for differentiation and proof of concept data for the application of the resulting cells in drug/nephrotoxicity screening and cellular therapy. The validity of the kidney organoids as a model of the developing organ will be interrogated using expression profiling, including single cell RNA-seq analyses. Single, double and triple fluorescent reporter iPSC lines will be generated to facilitate the subsequent isolation of specifi cell types from the organoids post differentiation. These cell types will also be characterized, providing novel information about specific kidney cell types during human development. Validating the use of organoids as a model of the developing organ will be performed so as to develop the use of organoids for drug/nephrotoxicity screening. Reporter iPSC lines will also be generated to report defined responses to injury. Nephrotoxicity screening will be performed on organoids generated using such reporter. Specific kidney cell types will be isolated from organoids via FACS and used to evaluate cellular therapy approaches for the treatment of chronic kidney injury via transplantation into immunocompromised mice. Reporter iPSC lines will also be generated to incorporate the expression of luciferase to allow for the monitoring via bioluminescence of the location of the delivered cells in live animals across time. The efficacy of delivering kidney cells derived from pluripotent stem cells into preclinical models will therefore be determined.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2021 ( Subtotal = -$9,517 )
2021	2019	MURDOCH CHILDRENS RESEARCH INSTITUTE	ROYAL CHILDRENS HOSPITAL FLEMINGTON RD	PARKVILLE	NULL			AUS	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	5	2/17/2021	NON-COMPETING CONTINUATION	-$9,517
														Subtotal = -$9,517

Issue Date FY: 2020 ( Subtotal = $0 )
2020	2019	MURDOCH CHILDRENS RESEARCH INSTITUTE	ROYAL CHILDRENS HOSPITAL FLEMINGTON RD	PARKVILLE		3052		AUS	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	5	7/14/2020	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2019 ( Subtotal = $345,722 )
2019	2019	MURDOCH CHILDRENS RESEARCH INSTITUTE	ROYAL CHILDRENS HOSPITAL FLEMINGTON RD	PARKVILLE		3052		AUS	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	5	8/8/2019	NON-COMPETING CONTINUATION	$345,722
														Subtotal = $345,722

Issue Date FY: 2018 ( Subtotal = $355,694 )
2018	2018	MURDOCH CHILDRENS RESEARCH INSTITUTE	ROYAL CHILDRENS HOSPITAL FLEMINGTON RD	PARKVILLE		3052		AUS	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	4	9/5/2018	NON-COMPETING CONTINUATION	$346,000
2018	2017	MURDOCH CHILDRENS RESEARCH INSTITUTE	ROYAL CHILDRENS HOSPITAL FLEMINGTON RD	PARKVILLE		3052		AUS	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	1/24/2018	EXTENSION WITH OR WITHOUT FUNDS	$9,694
														Subtotal = $355,694

Issue Date FY: 2017 ( Subtotal = $346,000 )
2017	2017	MURDOCH CHILDRENS RESEARCH INSTITUTE	ROYAL CHILDRENS HOSPITAL FLEMINGTON RD	PARKVILLE		3052		AUS	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	9/12/2017	EXTENSION WITH OR WITHOUT FUNDS	$346,000
														Subtotal = $346,000

Grand Total All Awards = $1,037,899

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Generating kidney organoids and mature renal cell types via directed iPSC differentiation

Award Number: UH3DK107344

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/25/2015

PERIOD OF PERFORMANCE END DATE: 08/31/2020

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer